1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Pharmacy Market?
The projected CAGR is approximately 21.2%.
U.S. Pharmacy MarketU.S. Pharmacy Market Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities
U.S. Pharmacy Market by Type (Branded, Generics), by Therapy Class (Oncology, Anti-diabetics, Autoimmune Diseases, Respiratory, Pain, Nervous System Disorders, Dermatology, Antihypertensive, Mental Health, HIV Antivirals, Multiple Sclerosis, Anticoagulants, Other Cardiovascular, ADHD, GI Products, Viral Hepatitis, Sex Hormones, Antibacterial, Hormonal Contraception, Ophthalmology, Others), by Setting (Retail Pharmacies, Mail Order/Online Pharmacies, Others), by Forecast 2025-2033
Base Year: 2024
180 Pages
U.S. Pharmacy Market Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities
U.S. Pharmacy Market Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities
Key Insights
The U.S. Pharmacy Market size was valued at USD 534.21 USD Billion in 2023 and is projected to reach USD 2052.25 USD Billion by 2032, exhibiting a CAGR of 21.2 % during the forecast period. Pharmacies are an essential part of the healthcare system in America, which provides prescription drugs and some other health services. They can be categorized into different categories such as community pharmacy, hospital pharmacy, clinical pharmacy and specialist pharmacy. The first type of retail pharmacy is community in nature and allows people to get their prescriptions, other drugs and medications that can be bought over the counter, and even health advice where necessary. In its broadest sense, hospital pharmacy is a busy professional practice that directly assists in-patient care by dispensing as well as monitoring patient-specific medication regimens. Clinical pharmacies are embedded as members of healthcare teams, enhancing medication use for improved patient and therapeutic outcomes; speciality pharmacies address specific and often unusual diseases and distribute unique and targeted products and services. Some of the major elements that characterize pharmacist practices in the United States include dispensing medications, counselling patients, provision of vaccination services and health check services. Largescale pharmacies also offer MTM services for the better management of chronic diseases among patients. The benefits of U. S. pharmacies are extensive: it helps in the safe use of medicines, enhance clients’ health, deliver universal and appropriate care as well as foster community health.
U.S. Pharmacy Trends
- significant shift towards speciality pharmacies
- Rising prevalence of chronic diseases
- Technological advancements in drug development and administration
Driving Forces: What's Propelling the U.S. Pharmacy Market
- Increasing healthcare expenditure
- Government initiatives to improve healthcare accessibility
- Growth in the biopharmaceutical industry
Challenges and Restraints in the U.S. Pharmacy Market
- Reimbursement challenges for specialty medications
- Price competition from generic drugs
- Regulatory compliance requirements
Emerging Trends in U.S. Pharmacy
- Telepharmacy and remote prescribing
- Data analytics and personalized medicine
- Value-based pricing models
Growth Catalysts in U.S. Pharmacy Industry
- Aging population and lengthening life expectancy
- Government support for healthcare innovation, including R&D incentives and funding for health IT
- Rising demand for personalized medicine, driven by advances in genomics and precision medicine
- Increasing prevalence of chronic diseases, such as diabetes and cardiovascular disease, leading to increased demand for long-term medication management
- Advent of specialty pharmaceuticals, including biologics and targeted therapies, which offer higher efficacy and lower side effects
Market Segmentation: U.S. Pharmacy Analysis
Type:
- Branded
- Generics
Therapy Class:
- Oncology
- Anti-diabetics
- Autoimmune Diseases
- Respiratory
- Pain
- Nervous System Disorders
- Dermatology
- Antihypertensive
- Mental Health
- HIV Antivirals
- Multiple Sclerosis
- Anticoagulants
- Other Cardiovascular
- ADHD
- GI Products
- Viral Hepatitis
- Sex Hormones
- Antibacterial
- Hormonal Contraception
- Ophthalmology
- Others
Setting:
- Retail Pharmacies
- Mail Order/Online Pharmacies
- Others
Leading Players in the U.S. Pharmacy Market
- CVS Health Corporation
- Walgreens Boots Alliance, Inc.
- Cigna (Express Scripts)
- UnitedHealth Group (Optum)
- Walmart Inc.
- The Kroger Company
- Rite Aid Corporation
- Albertsons Companies, Inc.
Significant Developments in the U.S. Pharmacy Sector
- Expansion of speciality pharmacy services
- Partnerships between pharmacies and healthcare providers
- Investment in innovative technologies
Comprehensive Coverage U.S. Pharmacy Market Report
- Thorough market analysis and forecast, providing detailed insights into current and future dynamics, including key trends, growth drivers, and challenges.
- In-depth segmentation based on type (retail pharmacy, hospital pharmacy, mail-order pharmacy), therapy class (cardiovascular, oncology, infectious diseases), and setting (urban, rural, tribal).
- Extensive competitive landscape analysis, profiling key industry players, assessing their market share, product portfolio, expansions, and growth strategies.
- Comprehensive analysis of market growth drivers and challenges, considering factors such as demographic shifts, healthcare policy changes, technological advancements, and rising consumer expectations.
- SWOT analysis, evaluating the strengths, weaknesses, opportunities, and threats faced by the U.S. pharmacy industry, providing strategic insights for businesses.
Regional Insight
- United States is the dominant segment, accounting for the largest market share
- Emerging economies, such as China and India, are expected to contribute to future growth due to rising healthcare spending and increasing demand for pharmaceuticals
- Regional differences in healthcare policies, reimbursement models, and drug pricing can impact market dynamics and growth prospects in different regions
DROCT
- Drivers: Aging population, rising incidence of chronic diseases
- Restraints: Reimbursement challenges, price competition
- Opportunities: Specialty pharmaceuticals, personalized medicine
- Challenges: Regulatory compliance, healthcare costs
Pricing Analysis
- Prices vary based on drug type, dosage, and manufacturer
- Discount programs and price negotiations are available
Import And Export Analysis
- Significant imports of specialty pharmaceuticals
- Exports of over-the-counter drugs
Segmentation
- Market segmented by type, therapy class, setting, and region
Patent/Trademark Analysis
- Intellectual property protection plays a vital role in the industry
U.S. Pharmacy Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 21.2% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Number of Surgical Procedures to Boost Market Growth
- 3.3. Market Restrains
- 3.3.1. Product Recalls and Lawsuits to Hinder Market Growth
- 3.4. Market Trends
- 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. U.S. Pharmacy Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Branded
- 5.1.2. Generics
- 5.2. Market Analysis, Insights and Forecast - by Therapy Class
- 5.2.1. Oncology
- 5.2.2. Anti-diabetics
- 5.2.3. Autoimmune Diseases
- 5.2.4. Respiratory
- 5.2.5. Pain
- 5.2.6. Nervous System Disorders
- 5.2.7. Dermatology
- 5.2.8. Antihypertensive
- 5.2.9. Mental Health
- 5.2.10. HIV Antivirals
- 5.2.11. Multiple Sclerosis
- 5.2.12. Anticoagulants
- 5.2.13. Other Cardiovascular
- 5.2.14. ADHD
- 5.2.15. GI Products
- 5.2.16. Viral Hepatitis
- 5.2.17. Sex Hormones
- 5.2.18. Antibacterial
- 5.2.19. Hormonal Contraception
- 5.2.20. Ophthalmology
- 5.2.21. Others
- 5.3. Market Analysis, Insights and Forecast - by Setting
- 5.3.1. Retail Pharmacies
- 5.3.2. Mail Order/Online Pharmacies
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1.
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North America U.S. Pharmacy Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 6.1.1 United States
- 6.1.2 Canada
- 6.1.3 Mexico
- 7. South America U.S. Pharmacy Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.1.1 Brazil
- 7.1.2 Argentina
- 7.1.3 Rest of South America
- 8. Europe U.S. Pharmacy Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.1.1 Germany
- 8.1.2 France
- 8.1.3 Italy
- 8.1.4 United Kingdom
- 8.1.5 Netherlands
- 8.1.6 Rest of Europe
- 9. Asia Pacific U.S. Pharmacy Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.1.1 China
- 9.1.2 Japan
- 9.1.3 India
- 9.1.4 South Korea
- 9.1.5 Taiwan
- 9.1.6 Australia
- 9.1.7 Rest of Asia-Pacific
- 10. MEA U.S. Pharmacy Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.1.1 Middle East
- 10.1.2 Africa
- 11. Competitive Analysis
- 11.1. Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 CVS Health Corporation (Rhode Island U.S.)
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Walgreens Boots Alliance Inc. (Illinois
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 U.S.)
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Cigna (Express Scripts) (Connecticut U.S.)
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 UnitedHealth Group (Optum) (Minnesota U.S.)
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Walmart Inc. (Arkansas U.S.)
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 The Kroger Company (Ohio U.S.)
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Rite Aid Corporation (Pennsylvania U.S.)
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Albertsons Companies Inc. (Idaho
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 U.S.)
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.1 CVS Health Corporation (Rhode Island U.S.)
List of Figures
- Figure 1: U.S. Pharmacy Market Revenue Breakdown (USD Billion, %) by Product 2024 & 2032
- Figure 2: U.S. Pharmacy Market Share (%) by Company 2024
List of Tables
- Table 1: U.S. Pharmacy Market Revenue USD Billion Forecast, by Region 2019 & 2032
- Table 2: U.S. Pharmacy Market Volume million units Forecast, by Region 2019 & 2032
- Table 3: U.S. Pharmacy Market Revenue USD Billion Forecast, by Type 2019 & 2032
- Table 4: U.S. Pharmacy Market Volume million units Forecast, by Type 2019 & 2032
- Table 5: U.S. Pharmacy Market Revenue USD Billion Forecast, by Therapy Class 2019 & 2032
- Table 6: U.S. Pharmacy Market Volume million units Forecast, by Therapy Class 2019 & 2032
- Table 7: U.S. Pharmacy Market Revenue USD Billion Forecast, by Setting 2019 & 2032
- Table 8: U.S. Pharmacy Market Volume million units Forecast, by Setting 2019 & 2032
- Table 9: U.S. Pharmacy Market Revenue USD Billion Forecast, by Region 2019 & 2032
- Table 10: U.S. Pharmacy Market Volume million units Forecast, by Region 2019 & 2032
- Table 11: U.S. Pharmacy Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 12: U.S. Pharmacy Market Volume million units Forecast, by Country 2019 & 2032
- Table 13: United States U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 14: United States U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 15: Canada U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 16: Canada U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 17: Mexico U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 18: Mexico U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 19: U.S. Pharmacy Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 20: U.S. Pharmacy Market Volume million units Forecast, by Country 2019 & 2032
- Table 21: Brazil U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 22: Brazil U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 23: Argentina U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 24: Argentina U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 25: Rest of South America U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 26: Rest of South America U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 27: U.S. Pharmacy Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 28: U.S. Pharmacy Market Volume million units Forecast, by Country 2019 & 2032
- Table 29: Germany U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 30: Germany U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 31: France U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 32: France U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 33: Italy U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 34: Italy U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 35: United Kingdom U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 36: United Kingdom U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 37: Netherlands U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 38: Netherlands U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 39: Rest of Europe U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 40: Rest of Europe U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 41: U.S. Pharmacy Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 42: U.S. Pharmacy Market Volume million units Forecast, by Country 2019 & 2032
- Table 43: China U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 44: China U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 45: Japan U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 46: Japan U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 47: India U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 48: India U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 49: South Korea U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 50: South Korea U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 51: Taiwan U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 52: Taiwan U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 53: Australia U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 54: Australia U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 55: Rest of Asia-Pacific U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 56: Rest of Asia-Pacific U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 57: U.S. Pharmacy Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 58: U.S. Pharmacy Market Volume million units Forecast, by Country 2019 & 2032
- Table 59: Middle East U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 60: Middle East U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 61: Africa U.S. Pharmacy Market Revenue (USD Billion) Forecast, by Application 2019 & 2032
- Table 62: Africa U.S. Pharmacy Market Volume (million units) Forecast, by Application 2019 & 2032
- Table 63: U.S. Pharmacy Market Revenue USD Billion Forecast, by Type 2019 & 2032
- Table 64: U.S. Pharmacy Market Volume million units Forecast, by Type 2019 & 2032
- Table 65: U.S. Pharmacy Market Revenue USD Billion Forecast, by Therapy Class 2019 & 2032
- Table 66: U.S. Pharmacy Market Volume million units Forecast, by Therapy Class 2019 & 2032
- Table 67: U.S. Pharmacy Market Revenue USD Billion Forecast, by Setting 2019 & 2032
- Table 68: U.S. Pharmacy Market Volume million units Forecast, by Setting 2019 & 2032
- Table 69: U.S. Pharmacy Market Revenue USD Billion Forecast, by Country 2019 & 2032
- Table 70: U.S. Pharmacy Market Volume million units Forecast, by Country 2019 & 2032
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.
Frequently Asked Questions
2. Which companies are prominent players in the U.S. Pharmacy Market?
Key companies in the market include CVS Health Corporation (Rhode Island, U.S.), Walgreens Boots Alliance, Inc. (Illinois, U.S.), Cigna (Express Scripts) (Connecticut, U.S.), UnitedHealth Group (Optum) (Minnesota, U.S.), Walmart Inc. (Arkansas, U.S.), The Kroger Company (Ohio, U.S.), Rite Aid Corporation (Pennsylvania, U.S.), Albertsons Companies, Inc. (Idaho, U.S.).
3. What are the main segments of the U.S. Pharmacy Market?
The market segments include Type, Therapy Class, Setting.
4. Can you provide details about the market size?
The market size is estimated to be USD 534.21 USD Billion as of 2022.
5. What are some drivers contributing to market growth?
Increasing Number of Surgical Procedures to Boost Market Growth.
6. What are the notable trends driving market growth?
Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.
7. Are there any restraints impacting market growth?
Product Recalls and Lawsuits to Hinder Market Growth.
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in USD Billion and volume, measured in million units.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "U.S. Pharmacy Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the U.S. Pharmacy Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the U.S. Pharmacy Market?
To stay informed about further developments, trends, and reports in the U.S. Pharmacy Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.